Vimarsana
Biggest News Aggregation in the World

Page 5 - Dirk Neum News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Dirk Neum. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Dirk Neum Today - Breaking & Trending Today

Biotest AG: Biotest treats first shingles patient with Varitect® CP in VARIZOSTA study - Vimarsana News

Biotest AG: Biotest treats first shingles patient with Varitect® CP in VARIZOSTA study

EQS-News: Biotest AG / Key word(s): StudyBiotest AG: Biotest treats first shingles patient with Varitect® CP in VARIZOSTA study 05.09.2023 / 09:00 CET/CESTThe issuer is solely responsible for the content of this announcement. PRESS RELEASE    Biotest treats first shingles patient with Varitect® CP in...

EQS-News: Biotest AG: Biotest Supervisory Board extends Management Board contract of Dr Jörg Schüttrumpf by 5 years - Vimarsana News

EQS-News: Biotest AG: Biotest Supervisory Board extends Management Board contract of Dr Jörg Schüttrumpf by 5 years

EQS-News: Biotest AG / Key word(s): Personnel Biotest AG: Biotest Supervisory Board extends Management Board contr...

Biotest AG: Biotest Supervisory Board extends Management Board contract of Dr Jörg Schüttrumpf by 5 years -Today at 06:11 am - Vimarsana News

Biotest AG: Biotest Supervisory Board extends Management Board contract of Dr Jörg Schüttrumpf by 5 years -Today at 06:11 am

EQS-News: Biotest AG / Key word: Personnel Biotest AG: Biotest Supervisory Board extends Management Board contract of Dr Jörg Schüttrumpf by 5 years...

Biotest AG: Biotest increases EBIT to Euro 19.8 million in the first half of 2023 - Vimarsana News

Biotest AG: Biotest increases EBIT to Euro 19.8 million in the first half of 2023

EQS-News: Biotest AG / Key word: Half Year Report Biotest AG: Biotest increases EBIT to Euro 19.8 million in the first half of 2023 10.08.2023 / 09:00... -Today at 03:01 am- MarketScreener

EQS-News: Biotest AG: Biotest increases EBIT to Euro 19.8 million in the first half of 2023 - Vimarsana News

EQS-News: Biotest AG: Biotest increases EBIT to Euro 19.8 million in the first half of 2023

EQS-News: Biotest AG / Key word(s): Half Year Report Biotest AG: Biotest increases EBIT to Euro 19.8 million in th...